Works by 常丽仙

Results: 14

艾米替诺福韦和富马酸替诺福韦对治疗乙肝肝纤维化的临床疗效比较.

Published in:

Journal of Practical Medicine / Shiyong Yixue Zazhi, 2024, v. 40, n. 22, p. 3215, doi. 10.3969/j.issn.1006-5725.2024.22.016

By:

张映媛;
牟春燕;
许丹青;
王远珍;
常丽仙;
刘春云;
李卫昆;
魏红艳;
刘立

Publication type:

Article

原发性肝癌干预前并发肺部感染风险预测模型的建立与验证.

Published in:

Tianjin Medical Journal, 2024, v. 52, n. 9, p. 940, doi. 10.11958/20240147

By:

王远珍;
魏红艳;
常丽仙;
张映媛;
刘春云;
刘立

Publication type:

Article

原发性肝癌干预前并发慢性肝衰竭的风险预测模型建立与评价.

Published in:

Journal of Kunming Medical University / Kunming Yike Daxue Xuebao, 2025, v. 46, n. 3, p. 139, doi. 10.12259/j.issn.2095-610X.S20250321

By:

王远珍;
魏红艳;
田仁海;
陈永臻;
许丹青;
张映媛;
常丽仙;
刘春云;
刘立

Publication type:

Article

原发性肝癌合并腹水患者发生 SBP 的风险预测分析.

Published in:

Journal of Kunming Medical University / Kunming Yike Daxue Xuebao, 2024, v. 45, n. 3, p. 133, doi. 10.12259/j.issn.2095-610X.S20240320

By:

魏红艳;
王远珍;
常丽仙;
木唤;
刘春云;
刘立

Publication type:

Article

预测普通病房中丙型肝炎肝硬化并脓毒症患者潜在死亡列线图的建立及评价.

Published in:

Journal of Kunming Medical University / Kunming Yike Daxue Xuebao, 2023, v. 44, n. 6, p. 113, doi. 10.12259/j.issn.2095-610X.S20230630

By:

薛淋淋;
李秉翰;
刘春云;
李卫昆;
常丽仙;
李慧敏;
祁燕伟;
刘立

Publication type:

Article

FibroScan、GPR评分、S指数、IL-6及TNF-α对HBeAg阳性慢性乙型肝炎肝纤维化的诊断价值.

Published in:

Journal of Clinical Hepatology / Linchuang Gandanbing Zazhi, 2025, v. 41, n. 4, p. 670, doi. 10.12449/JCH250411

By:

张, 映媛;
许, 丹青;
木, 唤;
牟, 春燕;
常, 丽仙;
王, 远珍;
魏, 红艳;
刘, 立;
李, 卫昆;
刘, 春云

Publication type:

Article

丙型肝炎肝硬化失代偿患者再代偿的影响因素分析.

Published in:

Journal of Clinical Hepatology / Linchuang Gandanbing Zazhi, 2025, v. 41, n. 2, p. 269, doi. 10.12449/JCH250212

By:

许, 丹青;
木, 唤;
张, 映媛;
常, 丽仙;
王, 远珍;
李, 卫昆;
董, 智坚;
张, 丽华;
程, 怡菁;
刘, 立

Publication type:

Article

原发性肝癌干预前并发肝性胸腔积液的危险因素及列线图预测模型构建.

Published in:

Journal of Clinical Hepatology / Linchuang Gandanbing Zazhi, 2025, v. 41, n. 1, p. 75, doi. 10.12449/JCH250112

By:

王, 远珍;
田, 仁海;
张, 映媛;
许, 丹青;
常, 丽仙;
刘, 春云;
刘, 立

Publication type:

Article

索磷布韦/维帕他韦单用或联合利巴韦林治疗3B型HCV/HIV 感染者的效果及安全性.

Published in:

Journal of Clinical Hepatology / Linchuang Gandanbing Zazhi, 2024, v. 40, n. 2, p. 271, doi. 10.12449/JCH240209

By:

刘立;
常丽仙;
陈智勇;
李俊义;
刘春云

Publication type:

Article

HBV感染家庭聚集性传播的影响因素及远期结局情况分析.

Published in:

Journal of Clinical Hepatology / Linchuang Gandanbing Zazhi, 2023, v. 39, n. 9, p. 2087, doi. 10.3969/j.issn.1001-5256.2023.09.009

By:

刘立;
常丽仙;
牟春燕;
张映媛;
李惠敏;
罗煜;
李俊义;
刘春云

Publication type:

Article

肝硬化合并脓毒症患者短期住院死亡的 Cox 比例风险预测模型建立及评价.

Published in:

Journal of Clinical Hepatology / Linchuang Gandanbing Zazhi, 2023, v. 39, n. 5, p. 1089, doi. 10.3969/j.issn.1001-5256.2023.05.013

By:

薛淋淋;
李秉翰;
刘春云;
李卫昆;
常丽仙;
刘立

Publication type:

Article

肝爽颗粒联合恩替卡韦对乙型肝炎肝硬化患者门静脉血栓发生的影响 .

Published in:

Journal of Clinical Hepatology / Linchuang Gandanbing Zazhi, 2022, v. 38, n. 9, p. 2020, doi. 10.3969/j.issn.1001-5256.2022.09.015

By:

刘立;
李俊义;
刘春云;
常丽仙;
张丽华;
黄红丽;
罗煜;
高建鹏

Publication type:

Article

HBV 感染免疫耐受期肝组织炎症和纤维化的影响因素分析.

Published in:

Journal of Clinical Hepatology / Linchuang Gandanbing Zazhi, 2022, v. 38, n. 9, p. 2005, doi. 10.3969/j.issn.1001-5256.2022.09.012

By:

刘春云;
常丽仙;
李俊义;
祁燕伟;
李卫昆;
李惠敏;
张映媛;
高建鹏;
刘立

Publication type:

Article

聚乙二醇干扰素α-2a治疗HBeAg阳性慢性乙型肝炎患儿的疗效观察.

Published in:

Journal of Clinical Hepatology / Linchuang Gandanbing Zazhi, 2015, v. 31, n. 2, p. 193, doi. 10.3969/j.issn.1001-5256.2015.02.012

By:

刘云华;
李震;
刘立;
彭丹;
李卫昆;
常丽仙;
贾婷;
杨永锐;
李惠敏;
王黎茜

Publication type:

Article